Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2021 | 05-2021 | 03-2021 | 02-2021 | 11-2020 | |
Operating Expenses | 2,254 | 2,251 | 1,696 | 1,868 | 1,436 |
Operating Income | -2,254 | -2,251 | -1,696 | -1,868 | -1,436 |
Interest Expense | 0 | 0 | 0 | 0 | 1 |
Other Income | 2 | 2 | 1 | 2 | 0 |
Pre-tax Income | -2,252 | -2,250 | -1,695 | -1,866 | -1,437 |
Net Income Continuous | -2,252 | -2,250 | -1,695 | -1,866 | -1,437 |
Net Income | $-2,252 | $-2,250 | $-1,695 | $-1,866 | $-1,437 |
EPS Basic Total Ops | -1.50 | -1.50 | -1.35 | -1.65 | -2.10 |
EPS Basic Continuous Ops | -1.44 | -1.46 | -1.29 | -1.65 | -2.11 |
EPS Diluted Total Ops | -1.50 | -1.50 | -1.35 | -1.65 | -2.10 |
EPS Diluted Continuous Ops | -1.44 | -1.46 | -1.29 | -1.65 | -2.11 |
EBITDA(a) | $-2,254 | $-2,251 | $-1,696 | $-1,867 | $-1,436 |